Review of icatibant use in the Winnipeg Regional Health Authority

This is a retrospective review of the Winnipeg Regional Health Authority ’s (WRHA) angioedema patients who were dispensed icatibant in hospital. Icatibant is a bradykinin B2 receptor antagonist indicated for He...

Source: Allergy, Asthma and Clinical Immunology - November 11, 2020 Category: Allergy & Immunology Authors: George Cai, Colin Barber and Chrystyna Kalicinsky Tags: Research Source Type: research